Plexpress Secures $2.3M in Funding | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helsinki, Finland-based Plexpress said today that it has raised up to $2.3 million in funding to expand sales of its Transcript Analysis with the Aid of Affinity Capture, or TRAC, platform for high-content gene expression analysis.

Four existing investors and one new investor have invested $1.4 million in the company and have committed an additional $900,000 should Plexpress reach certain milestones.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.